Atricure Stock Technical Analysis

ATRC Stock  USD 36.95  0.82  2.17%   
As of the 30th of January, AtriCure shows the Risk Adjusted Performance of 0.0141, downside deviation of 3.15, and Mean Deviation of 2.4. AtriCure technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

AtriCure Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as AtriCure, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AtriCureAtriCure's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

AtriCure Analyst Consensus

Target PriceAdvice# of Analysts
52.78Strong Buy9Odds
AtriCure current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most AtriCure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AtriCure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AtriCure, talking to its executives and customers, or listening to AtriCure conference calls.
AtriCure Analyst Advice Details
Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.61)
Revenue Per Share
10.902
Quarterly Revenue Growth
0.158
Return On Assets
(0.03)
Return On Equity
(0.06)
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value—what AtriCure's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

AtriCure 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AtriCure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AtriCure.
0.00
11/01/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/30/2026
0.00
If you would invest  0.00  in AtriCure on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding AtriCure or generate 0.0% return on investment in AtriCure over 90 days. AtriCure is related to or competes with Quidel, BioLife Solutions, Kestra Medical, Azenta, 10X Genomics, Novocure, and Xeris Pharmaceuticals. AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and in... More

AtriCure Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AtriCure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AtriCure upside and downside potential and time the market with a certain degree of confidence.

AtriCure Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for AtriCure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AtriCure's standard deviation. In reality, there are many statistical measures that can use AtriCure historical prices to predict the future AtriCure's volatility.
Hype
Prediction
LowEstimatedHigh
33.6136.9540.29
Details
Intrinsic
Valuation
LowRealHigh
31.0334.3737.71
Details
Naive
Forecast
LowNextHigh
34.0437.3840.72
Details
9 Analysts
Consensus
LowTargetHigh
48.0352.7858.58
Details

AtriCure January 30, 2026 Technical Indicators

AtriCure Backtested Returns

At this point, AtriCure is very steady. AtriCure secures Sharpe Ratio (or Efficiency) of 0.0572, which signifies that the company had a 0.0572 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for AtriCure, which you can use to evaluate the volatility of the firm. Please confirm AtriCure's Mean Deviation of 2.4, downside deviation of 3.15, and Risk Adjusted Performance of 0.0141 to double-check if the risk estimate we provide is consistent with the expected return of 0.19%. AtriCure has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.59, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. AtriCure right now shows a risk of 3.36%. Please confirm AtriCure treynor ratio, kurtosis, relative strength index, as well as the relationship between the downside variance and day median price , to decide if AtriCure will be following its price patterns.

Auto-correlation

    
  -0.49  

Modest reverse predictability

AtriCure has modest reverse predictability. Overlapping area represents the amount of predictability between AtriCure time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AtriCure price movement. The serial correlation of -0.49 indicates that about 49.0% of current AtriCure price fluctuation can be explain by its past prices.
Correlation Coefficient-0.49
Spearman Rank Test-0.53
Residual Average0.0
Price Variance2.36
AtriCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AtriCure technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AtriCure trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

AtriCure Technical Analysis

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of AtriCure volatility developed by Welles Wilder.

About AtriCure Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of AtriCure on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of AtriCure based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on AtriCure price pattern first instead of the macroeconomic environment surrounding AtriCure. By analyzing AtriCure's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of AtriCure's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to AtriCure specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 2026 (projected)
Days Sales Outstanding48.047.3354.4356.96
PTB Ratio3.553.112.83.71

AtriCure January 30, 2026 Technical Indicators

Most technical analysis of AtriCure help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for AtriCure from various momentum indicators to cycle indicators. When you analyze AtriCure charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

AtriCure January 30, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as AtriCure stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets